Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (August 17, 2020) -- Johnson & Johnson (NYSE: JNJ) will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 10:40 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately two hours after the live webcast.

      You are now leaving JNJ.com and going to a site with a different privacy policy. Please click below to continue to that site.